Mark E. Tryniski - 01 Jun 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
Sarah M Oliker for Mark E. Tryniski by Power of Attorney
Issuer symbol
CNMD
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
03 Jun 2021, 14:31:28 UTC
Next filing
16 Sep 2021
SEC
View on sec.gov

Quoteable Key Fact

"Mark E. Tryniski filed Form 4 for CONMED Corp (CNMD) on 03 Jun 2021."

Quick Takeaways

  • This page summarizes Mark E. Tryniski's Form 4 filing for CONMED Corp (CNMD).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Filing timestamp: 03 Jun 2021, 14:31.

What Changed

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

CNMD transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,521
Change %
+3.5%
Price
$0.000000
Shares after
44,410
Date
01 Jun 2021
Ownership
Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

CNMD transaction Derivative

Rsus (restricted Stock Units)

Options Exercise

Transaction value
$0
Shares
-1,521
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,521
Exercise price
$0.000000
CNMD transaction Derivative

Rsus (restricted Stock Units)

Award

Transaction value
$0
Shares
+812
Change %
Price
$0.000000
Shares after
812
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
812
Exercise price
$0.000000
Footnotes
F1
CNMD transaction Derivative

Options To Purchase Common Stock

Award

Transaction value
$0
Shares
+865
Change %
Price
$0.000000
Shares after
865
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
865
Exercise price
$138.45
Footnotes
F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .